Hospital Universitario 12 de Octubre-Centro de Actividades Ambulatorias

Madrid 28041

0 studies enrolling now · 4 studies all time

What they study most

Antibody-mediated Rejection, Cutaneous Squamous Cell Carcinoma, Peripheral T Cell Lymphoma, Solid Tumor, Transformed Mycosis Fungoides

Studies at this site

• Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors — Stopped early
• Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma — Running, not enrolling
• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
• Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides — Completed